Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210334637> ?p ?o ?g. }
- W4210334637 endingPage "e0263240" @default.
- W4210334637 startingPage "e0263240" @default.
- W4210334637 abstract "Elderly patients with acute myeloid leukemia not eligible for intensive antileukemic therapy are treated with less intensive therapies, uncertainty remains regarding their relative merits.To compare the effectiveness and safety of less intensive antileukemic therapies for older adults with newly diagnosed AML not candidates for intensive therapies.We included randomized controlled trials (RCTs) and non-randomized studies (NRS) comparing less intensive therapies in adults over 55 years with newly diagnosed AML. We searched MEDLINE and EMBASE from inception to August 2021. We assessed risk of bias of RCTs with a modified Cochrane Risk of Bias tool, and NRS with the Non-Randomized Studies of Interventions tool (ROBINS-I). We calculated pooled hazard ratios (HRs), risk ratios (RRs), mean differences (MD) and their 95% confidence intervals (CIs) using a random-effects pairwise meta-analyses and assessed the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.We included 27 studies (17 RCTs, 10 NRS; n = 5,698), which reported 9 comparisons. Patients were treated with azacitidine, decitabine, and low-dose cytarabine (LDAC), as monotherapies or in combination with other agents. Moderate certainty of evidence suggests no convincing difference in overall survival of patients who receive azacitidine monotherapy compared to LDAC monotherapy (HR 0.69; 95% CI, 0.31-1.53), fewer febrile neutropenia events occurred between azacitidine monotherapy to azacitidine combination (RR 0.45; 95% CI, 0.31-0.65), and, fewer neutropenia events occurred between LDAC monotherapy to decitabine monotherapy (RR 0.62; 95% CI 0.44-0.86). All other comparisons and outcomes had low or very low certainty of evidence.There is no convincing superiority in OS when comparing less intensive therapies. Azacitidine monotherapy is likely to have fewer adverse events than azacitidine combination (febrile neutropenia), and LDAC monotherapy is likely to have fewer adverse events than decitabine monotherapy (neutropenia)." @default.
- W4210334637 created "2022-02-08" @default.
- W4210334637 creator A5007697163 @default.
- W4210334637 creator A5017098288 @default.
- W4210334637 creator A5020341898 @default.
- W4210334637 creator A5031717153 @default.
- W4210334637 creator A5046837544 @default.
- W4210334637 creator A5055740968 @default.
- W4210334637 creator A5076552127 @default.
- W4210334637 creator A5085360755 @default.
- W4210334637 date "2022-02-02" @default.
- W4210334637 modified "2023-09-26" @default.
- W4210334637 title "Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis" @default.
- W4210334637 cites W1600365609 @default.
- W4210334637 cites W1967486444 @default.
- W4210334637 cites W1994169292 @default.
- W4210334637 cites W2018074634 @default.
- W4210334637 cites W2028627376 @default.
- W4210334637 cites W2046180917 @default.
- W4210334637 cites W2046802229 @default.
- W4210334637 cites W2047586716 @default.
- W4210334637 cites W2076571981 @default.
- W4210334637 cites W2090132603 @default.
- W4210334637 cites W2093043874 @default.
- W4210334637 cites W2101725260 @default.
- W4210334637 cites W2106084333 @default.
- W4210334637 cites W2109346853 @default.
- W4210334637 cites W2125347906 @default.
- W4210334637 cites W2128168358 @default.
- W4210334637 cites W2143835472 @default.
- W4210334637 cites W2157287007 @default.
- W4210334637 cites W2165010366 @default.
- W4210334637 cites W2171892885 @default.
- W4210334637 cites W2172277773 @default.
- W4210334637 cites W2464037156 @default.
- W4210334637 cites W2543349776 @default.
- W4210334637 cites W2605196669 @default.
- W4210334637 cites W2611278239 @default.
- W4210334637 cites W2739796560 @default.
- W4210334637 cites W2778072486 @default.
- W4210334637 cites W2783500974 @default.
- W4210334637 cites W2792308249 @default.
- W4210334637 cites W2884965254 @default.
- W4210334637 cites W2898284215 @default.
- W4210334637 cites W2904032061 @default.
- W4210334637 cites W2905344869 @default.
- W4210334637 cites W2911607353 @default.
- W4210334637 cites W2943784761 @default.
- W4210334637 cites W2944112179 @default.
- W4210334637 cites W2992296498 @default.
- W4210334637 cites W2997079384 @default.
- W4210334637 cites W2998104471 @default.
- W4210334637 cites W3011467845 @default.
- W4210334637 cites W3013447738 @default.
- W4210334637 cites W3023552461 @default.
- W4210334637 cites W3030429552 @default.
- W4210334637 cites W3047569349 @default.
- W4210334637 cites W3048827006 @default.
- W4210334637 cites W3146142859 @default.
- W4210334637 cites W3152804121 @default.
- W4210334637 cites W369237374 @default.
- W4210334637 doi "https://doi.org/10.1371/journal.pone.0263240" @default.
- W4210334637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35108310" @default.
- W4210334637 hasPublicationYear "2022" @default.
- W4210334637 type Work @default.
- W4210334637 citedByCount "1" @default.
- W4210334637 countsByYear W42103346372022 @default.
- W4210334637 crossrefType "journal-article" @default.
- W4210334637 hasAuthorship W4210334637A5007697163 @default.
- W4210334637 hasAuthorship W4210334637A5017098288 @default.
- W4210334637 hasAuthorship W4210334637A5020341898 @default.
- W4210334637 hasAuthorship W4210334637A5031717153 @default.
- W4210334637 hasAuthorship W4210334637A5046837544 @default.
- W4210334637 hasAuthorship W4210334637A5055740968 @default.
- W4210334637 hasAuthorship W4210334637A5076552127 @default.
- W4210334637 hasAuthorship W4210334637A5085360755 @default.
- W4210334637 hasBestOaLocation W42103346371 @default.
- W4210334637 hasConcept C104317684 @default.
- W4210334637 hasConcept C126322002 @default.
- W4210334637 hasConcept C143998085 @default.
- W4210334637 hasConcept C150194340 @default.
- W4210334637 hasConcept C168563851 @default.
- W4210334637 hasConcept C185592680 @default.
- W4210334637 hasConcept C190727270 @default.
- W4210334637 hasConcept C207103383 @default.
- W4210334637 hasConcept C2776239401 @default.
- W4210334637 hasConcept C2776694085 @default.
- W4210334637 hasConcept C2776999253 @default.
- W4210334637 hasConcept C2777063308 @default.
- W4210334637 hasConcept C2778041864 @default.
- W4210334637 hasConcept C2778729363 @default.
- W4210334637 hasConcept C2778850193 @default.
- W4210334637 hasConcept C2780235182 @default.
- W4210334637 hasConcept C44249647 @default.
- W4210334637 hasConcept C55493867 @default.
- W4210334637 hasConcept C71924100 @default.
- W4210334637 hasConcept C82789193 @default.
- W4210334637 hasConcept C95190672 @default.